2002
DOI: 10.1016/s1047-2797(01)00231-9
|View full text |Cite
|
Sign up to set email alerts
|

Epidemiologic Features of HTLV-II Serologic and Molecular Evidence

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
23
0
2

Year Published

2005
2005
2017
2017

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(26 citation statements)
references
References 142 publications
1
23
0
2
Order By: Relevance
“…HTLV-1 is more frequent among injection drug users in Brazil and New York [34][35][36][37][38] , whereas HTLV-2 is more prevalent in injection drug users in other locations in North America and in Europe [39][40][41][42][43][44] . In 2001, the fi rst cases of HTLV-1 transmission through organs that were transplanted from asymptomatic infected donors were reported in Europe; three donor organ recipients developed subacute myelopathy shortly after transplantation 45 .…”
Section: Modes Of Htlv Transmissionmentioning
confidence: 99%
“…HTLV-1 is more frequent among injection drug users in Brazil and New York [34][35][36][37][38] , whereas HTLV-2 is more prevalent in injection drug users in other locations in North America and in Europe [39][40][41][42][43][44] . In 2001, the fi rst cases of HTLV-1 transmission through organs that were transplanted from asymptomatic infected donors were reported in Europe; three donor organ recipients developed subacute myelopathy shortly after transplantation 45 .…”
Section: Modes Of Htlv Transmissionmentioning
confidence: 99%
“…HTLV-1 is the causative agent of adult T-cell leukemia (ATL), a malignant transformation of CD4 + T lymphocytes (2), and HTLV-1 associated myelopathy/ tropical spastic paraparesis (HAM/TSP), a chronic progressive neurological disease (3). Although HTLV-2 was initially isolated from a patient with a rare variant of hairy T-cell leukemia (4)(5), its disease association is less clear (6). However, there have been a few reports of HTLV-2 association with a neurodegenerative disease (7,8).…”
Section: Introductionmentioning
confidence: 99%
“…Human T cell lymphotropic virus type 2 (HTLV-II) shares 65% of its nucleotide sequences with human T cell lymphotropic virus type 1 (HTLV-I) 12 . HTLV-II has not been etiologically linked with any disease, although a number of case reports and a few cross-sectional studies suggest an association with a tropical spastic paraparesis/HTLVassociated myelopathy (TSP)-like syndrome 4,17 .…”
Section: Introductionmentioning
confidence: 99%